Recent Updates
Recently added Catalysts
STXS Positive Sentiment

Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023

Key Takeaway: Stereotaxis, a leader in surgical robotics for minimally invasive procedures, will announce its second-quarter financial results on August 10, 2023. A conference call is scheduled for the same day at 10 a.m. EST, where corporate developments will also be discussed. This provides an opportunity for investors and stakeholders to gain insights into the company's performance and future direction. Stereotaxis has been recognized for its innovative technologies and their impact on patient care across various regions.
Price reaction · baseline $1.49 (2023-07-14 close) · 1 other STXS headline(s) in the window, move may be shared
day 0 close
-0.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Stereotaxis is a leader in surgical robotics, indicating strong market position.
  • The company is committed to innovative solutions that enhance patient care.
  • Stereotaxis technology has positively impacted over 100,000 patients globally.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~8 mo
Medium dilution risk
Lead asset
Vdrive Lasso navigation, Manual Lasso navigation
Phase 3 · Atrial Fibrillation

Full Press Release Details

ST. LOUIS, July 17, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 second quarter on Thursday, August 10, 2023 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.
What: Stereotaxis second quarter 2023 financial results conference call
When: Thursday, August 10, 2023, at 10:00 a.m. ET (7:00 a.m. PT)
Dial In Number: To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 5648825.
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/ .
Call Replay: A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here .
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Frequently Asked Questions

When will Stereotaxis release its Q2 2023 financial results?

Stereotaxis will release its Q2 2023 financial results on August 10, 2023.

What time is the conference call on August 10, 2023?

The conference call is scheduled for 10 a.m. ET on August 10, 2023.

How can I access the Stereotaxis conference call?

Call 800-715-9871 (US) or 1-646-307-1963 (International) with pass code 5648825.

Where can I find the webcast for the financial results?

The webcast is available on the investor relations section of Stereotaxis’ website.

What is Stereotaxis known for in healthcare technology?

Stereotaxis specializes in robotic systems for minimally invasive endovascular interventions.

Last updated: Jul 17, 2023